Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 58, 102894
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaquesJournal of Antimicrobial Chemotherapy, 2015
- Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase InhibitorsScience Translational Medicine, 2014
- Knowledge of and Interest in Using Preexposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men in ThailandJournal of the International Association of Providers of AIDS Care (JIAPAC), 2013
- Timing of the Components of the HIV Life Cycle in Productively Infected CD4 + T Cells in a Population of HIV-Infected IndividualsJournal of Virology, 2011
- Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV InfectionScience Translational Medicine, 2010
- On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitorsJournal of Chromatography B, 2009
- Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and TenofovirPLOS Medicine, 2008
- Perils at mucosal front lines for HIV and SIV and their hostsNature Reviews Immunology, 2005
- Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic TissueAntimicrobial Agents and Chemotherapy, 2005
- METABOLISM OF GS-7340, A NOVEL PHENYL MONOPHOSPHORAMIDATE INTRACELLULAR PRODRUG OF PMPA, IN BLOODNucleosides, Nucleotides & Nucleic Acids, 2001